In addition, CISD1 expression was also significantly lower in myeloma, skin cancer, and testicular cancer compared with normal tissues and significantly higher in cervical squamous cell carcinoma, ovarian cancer, prostate cancer, and uterus cancer compared with normal tissues. This evidence concerns the gene CISD1 and prostate cancer.